Drug Type TCR therapy |
Synonyms JWTCR001 |
Target |
Mechanism MAGEA4 inhibitors(Melanoma-associated antigen 4 inhibitors), Immunologic cytotoxicity, T lymphocyte replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Solid tumor | Preclinical | CN | 18 Dec 2023 |